Impassion
14 Dec 2020
Impassion
NCT03498716
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
Roche
Cancer Type | Breast |
---|---|
Trial Type | Treatment |
Phase | All stages |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | All stages |
Anticipated Start Date | 2018-08-02 |
Anticipated End Date | - |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Dr Sid Selva |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs